Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Douglas A. McIntyre | Apr 19, 2007 at 8:19 AM EDT

Pfizer Looks Like a Bond Replacement – Earnings Preview (PFE)

Pfizer (PFE) reports on Friday, and just liketearing off a band-aid, investors are hoping the earnings release tobe quick, and…

Douglas A. McIntyre | Apr 19, 2007 at 7:23 AM EDT

Merck Does OK

Merck (MRK) announced what the market expected. On that note, they are already ahead of Yahoo!. Revenue hit $5.8 billion…

Douglas A. McIntyre | Apr 19, 2007 at 2:32 AM EDT

Wednesday’s Top Biotech & Medical Stocks

by H.S. AyoubBioHealth Investor.com

Douglas A. McIntyre | Apr 18, 2007 at 3:57 AM EDT

Ahead of the Earnings: Merck Gaining Respectability Again?

We can see the sweat on their brow, but all in all Merck (MRK) is running a pretty good race…

Douglas A. McIntyre | Apr 18, 2007 at 2:56 AM EDT

Tuesday’s Top Biotech & Medical Stocks

by H.S. AyoubBioHealth Investor.com

Douglas A. McIntyre | Apr 18, 2007 at 2:54 AM EDT

Targacept: Late Day Volume Surge Deserves Attention

by H.S. AyoubBioHealth Investor.com

Douglas A. McIntyre | Apr 17, 2007 at 1:29 PM EDT

Cervical Cancer Vaccine Wars Heating Up (GSK, MRK)

GlaxoSmithKline (GSK-NYSE/ADR) has just announced more positive data on its cervical cancer vaccine called CERVARIX(R). The company has said that…

Douglas A. McIntyre | Apr 17, 2007 at 6:39 AM EDT

Cell Genesys Showing New Positive Study Data

Cell Genesys, Inc. (CEGE-NASDAQ) is trading up more than 7% at $5.50 in earlybird trading on thin volume this morning…

Douglas A. McIntyre | Apr 17, 2007 at 3:11 AM EDT

Monday’s Top Biotech & Medical Stocks

From BioHealth Investor

Douglas A. McIntyre | Apr 16, 2007 at 12:18 PM EDT

Boston Scientific Begging For Good News

It’s always an interesting phenomenon when a large company becomes ultra-sensitive to news, as Boston Scientific (BSX) seems to be…

Douglas A. McIntyre | Apr 16, 2007 at 10:39 AM EDT

Peregrine “Compares” to Avastin

Peregrine Pharmaceuticals, Inc. (PPHM-NASDAQ) just issued a press release showing "Peregrine’s Selective Anti-VEGF Antibodies Inhibited Tumor Growth By 90% In…

Douglas A. McIntyre | Apr 13, 2007 at 10:53 AM EDT

Vertex Options Active Ahead of Data Presentation

Vertex (VRTX-NASDAQ) is seeing quite a bit of trading today ahead of a data presentation tomorrow. This one may have…

Douglas A. McIntyre | Apr 13, 2007 at 4:35 AM EDT

Someone At Merck Is Crazy

Merck’s new arthritis drug Arcoxia was rejected by an FDA panel by a vote of 20-to-1. Apparently, the drug has…

Douglas A. McIntyre | Apr 13, 2007 at 2:46 AM EDT

Thursday’s Top Biotech & Medical Stocks

by H.S. AyoubBioHealth Investor.com

Douglas A. McIntyre | Apr 12, 2007 at 3:00 PM EDT

Cramer Looking For the Next Dendreon

Cramer said in a video this afternoon on TheStreet.com that this Dendreon (DNDN-NASDAQ) is a classic case of short sellers…

1 … 372 373 374 375 376 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Pfizer Looks Like a Bond Replacement – Earnings Preview (PFE)

Merck Does OK

Wednesday’s Top Biotech & Medical Stocks

Ahead of the Earnings: Merck Gaining Respectability Again?

Tuesday’s Top Biotech & Medical Stocks

Targacept: Late Day Volume Surge Deserves Attention

Cervical Cancer Vaccine Wars Heating Up (GSK, MRK)

Cell Genesys Showing New Positive Study Data

Monday’s Top Biotech & Medical Stocks

Boston Scientific Begging For Good News

Peregrine “Compares” to Avastin

Vertex Options Active Ahead of Data Presentation

Someone At Merck Is Crazy

Thursday’s Top Biotech & Medical Stocks

Cramer Looking For the Next Dendreon

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Health and Healthcare Articles

All Health and Healthcare Articles

Pfizer Looks Like a Bond Replacement – Earnings Preview (PFE)

Merck Does OK

Wednesday’s Top Biotech & Medical Stocks

Ahead of the Earnings: Merck Gaining Respectability Again?

Tuesday’s Top Biotech & Medical Stocks

Targacept: Late Day Volume Surge Deserves Attention

Cervical Cancer Vaccine Wars Heating Up (GSK, MRK)

Cell Genesys Showing New Positive Study Data

Monday’s Top Biotech & Medical Stocks

Boston Scientific Begging For Good News

Peregrine “Compares” to Avastin

Vertex Options Active Ahead of Data Presentation

Someone At Merck Is Crazy

Thursday’s Top Biotech & Medical Stocks

Cramer Looking For the Next Dendreon

Mark Cuban’s Dire Prediction: Could These Trade Policies Trigger a Recession Worse Than 2008?

XRP Price: XRP ETFs Snapped Their Longest Inflow Streak of 2026 as Price Slips Below $1.40

Jim Cramer to Brinker’s CEO: How Do You Make More Money When Every Cost Is Going the Wrong Way?

Featured Reads

Retirees Are Realizing a $1.5 Million Nest Egg at 60 Only Means $31,000 in Real Annual Spending

71% of Americans With Financial Advisors Feel Secure. Only 10% Without One Do